15-min delayed · Sep 8, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 2 firms covering Aura Biosciences Inc, 2 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a strong buy consensus. Targets are tightly clustered, $13.00 to $18.00, so the covering firms are broadly aligned. The average target of $15.50 sits 111% above the current $7.36. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees revenue growth near 0% this year and 0% next, consensus EPS building from about $-0.35 next quarter toward $-1.52 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS2 ratings
Strong Buy
Strong Buy00%
Buy2100%
Hold00%
Sell00%
Strong Sell00%
Based on 2 analysts giving stock ratings to Aura Biosciences Inc.
As of Sep, 2 of 2 firms rate AURA a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
AURA EPS & revenue forecast
EPS · NEXT QUARTER
$-0.35
Range $-0.39 – $-0.27 · 4 analysts · -6% YoY
Next period, 4 analysts expect Aura Biosciences Inc to earn $-0.35 a share (range $-0.39 – $-0.27), versus $-0.37 a year earlier. Full-year consensus is $-1.67, growing to $-1.52 the year after.
REVENUE · NEXT QUARTER
$0
Range $0 – $0 · 4 analysts · +0% YoY
Revenue is expected to reach $0 (range $0 – $0), +0.0% year-over-year. Full-year consensus is $0, rising to $4.9M next year.
Top analysts covering Aura Biosciences Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on AURA.
#1
Jonathan Wolleben
JMP Securities · Rank #29
Buy
$19.00+158.2% to target
Overall win rate
47%
+ Follow
#2
Andrew Fein
HC Wainwright & Co. · Rank #55
Buy
$24.00+226.1% to target
Overall win rate
46%
+ Follow
#3
Andres Y. Maldonado
HC Wainwright & Co. · Rank #227
Buy
$18.00+144.6% to target
Overall win rate
39%
+ Follow
#4
JM
Jonathan Miller
Evercore ISI
Buy
$15.00+103.8% to target
Coverage
—
+ Follow
AURA stock forecast FAQ
What is AURA's average 12-month price target?+
The 2 analysts with a live target average $15.50 for Aura Biosciences Inc over the next 12 months, ranging from a $18.00 high to a $13.00 low.
Is AURA stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 2 analyst ratings, 2 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for AURA?+
The Street-high target is $18.00 (HC Wainwright & Co.), and the Street-low is $13.00 (Evercore ISI Group). The average of all 2 active targets is $15.50.
How many Wall Street analysts cover AURA?+
2 analysts have an active rating on Aura Biosciences Inc, and 2 firms carry a live 12-month price target.
Who is the most accurate analyst covering AURA?+
Among analysts who currently cover AURA, Jonathan Wolleben of JMP Securities has the strongest overall Quantellect track record (Rank #29). Their current call is Buy with a $19.00 target.
What is Aura Biosciences Inc's projected EPS for next quarter?+
The consensus estimate is $-0.35 per share (range $-0.39 – $-0.27) across 4 analysts. Full-year EPS is projected at $-1.67, rising to $-1.52 the following year.
How much revenue is Aura Biosciences Inc expected to report next quarter?+
Consensus revenue is $0 (range $0 – $0). Full-year revenue is projected at $0, growing to $4.9M next year.
Have analysts been upgrading or downgrading AURA lately?+
As of Sep, 2 of 2 firms rate AURA a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their AURA calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
